Navigation Links
PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director
Date:9/8/2009

LONDON, Sept. 8 /PRNewswire/ -- PriceSpective, a value strategy consultancy that provides pricing and reimbursement services to pharmaceutical and biotechnology companies, is pleased to announce that it has hired two senior experts for its UK office. Walter Colasante, as a Vice President, and Sophie Murdoch, as a Director, will help further strengthen PriceSpective's pricing and reimbursement expertise and expand its current offerings.

Colasante, who brings 20 years experience in healthcare, will contribute to PriceSpective's real world pricing and reimbursement knowledge and client guidance, and will enhance PriceSpective's forecasting and portfolio and risk management services. Reflective of PriceSpective's promise of active senior level project involvement, Colasante will be an immediate resource for clients.

Expanding PriceSpective's commercial and device expertise, Murdoch brings 12 years of pharmaceutical experience. Murdoch will play a key role in developing strategic guidance for clients that synchronizes pricing and commercial goals.

"With ever-increasing pressure on drug pricing and debates over healthcare reforms across the globe," said CEO Steve Slovick, "we are delighted to bring on two, outstanding senior-level experts whose unique and diverse experiences will ensure the continuation of high quality services to our clients in a dynamic marketplace. Meanwhile, UK-based partner Keiron Sparrowhawk said, "Walter and Sophie will be invaluable in the continued growth and expansion of PriceSpective, enabling us to further meet our clients' needs."

Previously, Colasante was the founder and Managing Director of Freelance Heath Services, which specialised in pharmaceutical forecasting, business analysis and intelligence, market access planning and epidemiology. Colasante's previous consulting experience includes serving as a General Manager at The Mattson Jack Group and as a Senior Engagement Director at IMS. Colasante has also worked in clinical development for Novartis, Allergan and BMS.

Previously, Murdoch was an Associate Director at BMS, where she was responsible for developing the EMEA commercialization strategy for IXEMPRA. Before BMS, Murdoch was a Global Associate Director Hydrofiber Franchise at ConvaTec, a Marketing Manager at SSL International, and an International Product Manager at Smith & Nephew.

About PriceSpective

PriceSpective is a management consulting firm specializing in innovative strategies to identify, capture and communicate value for companies in the biopharmaceutical arena. We are uniquely positioned to deliver expert guidance in integrated global pricing, reimbursement and market access strategy due to our depth of experience and the active engagement of our senior leadership.

Over the last year, PriceSpective has climbed from position #413 on Inc 500's list of 'Fastest Growing Private Companies in America' to # 174. PriceSpective has offices in Los Angeles, Philadelphia and London and has a global staff of 49 professionals.


'/>"/>
SOURCE PriceSpective
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PriceSpective Continues Global Expansion With New San Diego Office
2. iPierian Appoints Dr. Matthew J. Plunkett as Chief Financial Officer
3. Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
4. ERT Appoints New Associate Director of Business Development - Japan
5. NeurogesX Appoints New Board Director and Audit Committee Chairman
6. Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer
7. Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors
8. Nucleix Appoints Meirav Chovav Vice President of Strategic Affairs and to the Board of Directors
9. Spectral appoints new board member
10. Cellular Dynamics International Appoints Leroy Hood, M.D., Ph.D., and George Church, Ph.D., to its Scientific Advisory Board
11. China Sky One Medical, Inc. Appoints New Independent Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... Feb. 28, 2017 Sangamo Therapeutics, Inc. ... today reported its fourth quarter and full year ... "Early this year we rebranded our company as ... of genomic therapies using our industry leading platform ... and cell therapy," said Sandy Macrae , ...
(Date:2/27/2017)... 2017 A Europe-wide survey of institutes conducted ... animals in their research treat them with due care. The survey ... analysis of the results indicates that there is a strong commitment ... into practice the principles of the 3Rs (Refine, Reduce, Replace)  ... What are the ...
(Date:2/27/2017)... PRINCETON, N.J. and HAMILTON, ... Advaxis, Inc. (NASDAQ: ADXS ) ... late-stage biopharmaceutical companies focused on developing cancer immunotherapies, ... license to develop a novel cancer immunotherapy agent ... technology with SELLAS, patented WT1 targeted heteroclitic peptide ...
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... Rob Lowe ... public television series. This series, called "Informed," focuses on issues that are important to ... on the climate change issue, which has been a hot topic around the world ...
Breaking Biology Technology:
(Date:2/2/2017)... , Feb. 1, 2017  Central to ... and meaningful advances worldwide, The Japan Prize Foundation ... Prize, who have pushed the envelope in their ... and Communication. Three scientists are being recognized with ... achievements that not only contribute to the advancement ...
(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading ... a new solution aimed at combatting fraud, waste and ... was introduced at the Action on Disaster Relief conference ... meeting point for UN agencies and foreign assistance organizations ... Fraud, waste and abuse are a largely unacknowledged problem ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds simple ... sock that monitors vital signs and alerts parents ... infant,s oxygen saturation level drops. But pediatric experts ... to parents, with no evidence of medical benefits, ... are marketed aggressively to parents of healthy babies, ...
Breaking Biology News(10 mins):